- Home
- PRTA vs MATV Comparison
PRTA vs MATV Comparison
Compare PRTA & MATV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PRTA
- MATV
- Stock Information
- Founded
- PRTA 2012
- MATV 1995
- Country
- PRTA Ireland
- MATV United States
- Employees
- PRTA N/A
- MATV N/A
- Industry
- PRTA Biotechnology: Pharmaceutical Preparations
- MATV Paper
- Sector
- PRTA Health Care
- MATV Basic Materials
- Exchange
- PRTA Nasdaq
- MATV Nasdaq
- Market Cap
- PRTA 366.6M
- MATV 361.1M
- IPO Year
- PRTA N/A
- MATV 1995
- Fundamental
- Price
- PRTA $7.69
- MATV $9.39
- Analyst Decision
- PRTA Buy
- MATV Strong Buy
- Analyst Count
- PRTA 10
- MATV 1
- Target Price
- PRTA $24.29
- MATV $10.00
- AVG Volume (30 Days)
- PRTA 955.8K
- MATV 578.2K
- Earning Date
- PRTA 08-04-2025
- MATV 08-06-2025
- Dividend Yield
- PRTA N/A
- MATV 4.26%
- EPS Growth
- PRTA N/A
- MATV N/A
- EPS
- PRTA N/A
- MATV N/A
- Revenue
- PRTA $10,341,000.00
- MATV $1,967,300,000.00
- Revenue This Year
- PRTA N/A
- MATV $3.07
- Revenue Next Year
- PRTA $122.46
- MATV $2.30
- P/E Ratio
- PRTA N/A
- MATV N/A
- Revenue Growth
- PRTA N/A
- MATV N/A
- 52 Week Low
- PRTA $4.32
- MATV $4.34
- 52 Week High
- PRTA $23.66
- MATV $19.96
- Technical
- Relative Strength Index (RSI)
- PRTA 70.62
- MATV 71.71
- Support Level
- PRTA $6.61
- MATV $6.27
- Resistance Level
- PRTA $8.01
- MATV $6.66
- Average True Range (ATR)
- PRTA 0.40
- MATV 0.44
- MACD
- PRTA 0.10
- MATV 0.13
- Stochastic Oscillator
- PRTA 81.40
- MATV 88.95
About PRTA Prothena Corporation plc
Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases. The company's clinical pipeline of antibody-based product candidates targets a range of indications, including Amyloid Light-chain (AL) amyloidosis (NEOD001), Parkinson's disease and other related synucleinopathies (PRX002), and inflammatory diseases, including ATTR amyloidosis [Coramitug (PRX004)], Alzheimer's disease (PRX123), Neurodegeneration (PRXPRX019), and Others.
About MATV Mativ Holdings Inc.
Mativ Holdings Inc is a diversified producer of premium specialty papers and resin-based products. It manufactures and sells paper and reconstituted tobacco products to the tobacco industry as well as specialized paper products. The company operates in two segments namely Advanced Materials and Structures, which manufactures resin-based products used in specialty applications in the filtration, infrastructure and construction, transportation, industrial, and medical end-markets, and Engineered Papers, which produces cigarette papers and reconstituted tobacco products for cigarette and cigar manufacturers, as well as various other non-tobacco paper products.